Icotinib versus Cisplatin Plus Docetaxel as Adjuvant Chemotherapy in Patients with Stage II (N1+) Non-Small Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study

Overview of attention for article published in OncoTargets and therapy, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 1 blog post.

Source link : https://www.breast-cancers.com/2021/02/16/full-text-icotinib-versus-cisplatin-plus-docetaxel-as-adjuvant-chemothera…